Parnax Lab

160.50
+1.85
(1.17%)
Market Cap
184.32
EPS
8.37
PE Ratio (TTM)
15.43
Dividend Yield
0.00
Industry
Healthcare
52 Week High
193.50
52 Week low
81.00
PB Ratio
2.31
Debt to Equity
1.01
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
12.53 %
Net Income Growth
11.63 %
Cash Flow Change
-24.06 %
ROE
-3.24 %
ROCE
-22.56 %
EBITDA Margin (Avg.)
-8.93 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
104
72
95
107
111
96
90
163
168
190
197
Expenses
91
61
82
96
99
89
80
140
145
165
168
EBITDA
13
11
13
11
12
7
10
23
24
24
29
Operating Profit %
12 %
14 %
14 %
9 %
9 %
7 %
11 %
14 %
14 %
12 %
14 %
Depreciation
3
3
4
4
4
5
5
6
7
7
7
Interest
4
4
5
4
4
5
5
5
5
5
6
Profit Before Tax
5
4
5
3
5
-2
-0
12
12
12
16
Tax
1
1
1
2
1
1
0
4
4
2
4
Net Profit
4
3
4
1
3
-3
-0
8
9
10
12
EPS in ₹
5.01
2.95
4.33
1.24
3.89
-3.43
-0.43
9.70
7.80
8.38
10.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
83
79
86
87
95
107
106
154
145
189
Fixed Assets
36
38
47
44
51
58
60
72
77
90
Current Assets
38
31
31
37
37
46
39
71
57
72
Capital Work in Progress
1
2
0
0
0
3
5
3
2
21
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
46
39
38
43
43
46
42
78
66
79
Total Liabilities
83
79
86
87
95
107
106
154
145
189
Current Liabilities
31
29
36
37
36
53
54
81
63
82
Non Current Liabilities
27
23
18
18
23
22
19
24
20
35
Total Equity
25
28
31
33
36
33
33
48
62
72
Reserve & Surplus
17
19
23
24
27
24
24
37
51
60
Share Capital
9
9
9
9
9
9
9
10
12
12

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
-2
0
1
-1
0
-0
4
-3
-1
Investing Activities
-4
-6
-10
-5
-11
-13
-7
-17
-10
-32
Operating Activities
-0
4
16
13
9
9
6
9
21
16
Financing Activities
6
1
-5
-7
1
5
0
12
-14
15

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Apr 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
62.59 %
62.59 %
62.59 %
62.59 %
67.58 %
67.58 %
67.58 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.46 %
33.99 %
33.31 %
33.30 %
29.07 %
29.07 %
28.30 %
23.90 %
23.83 %
24.59 %
24.86 %
24.88 %
24.46 %
24.45 %
24.60 %
24.26 %
No of Share Holders
2,105
2,207
2,139
2,259
2,403
2,403
2,605
3,096
3,070
3,060
3,221
3,543
3,536
4,496
4,406
4,173

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,755.70 4,21,251.24 37.86 49,887.20 12.06 9,648 27.34 38.52
5,833.75 1,54,867.73 86.72 8,184.00 0.89 1,600 46.55 53.73
1,443.85 1,16,607.35 25.33 26,520.70 14.17 4,155 12.95 38.59
1,324.75 1,10,538.58 20.90 28,905.40 12.36 5,578 -9.47 52.74
3,205.85 1,08,500.53 63.29 10,785.70 11.59 1,656 17.36 39.68
2,609.95 1,07,677.90 52.12 10,615.60 19.57 1,942 28.89 42.33
987.65 99,380.70 23.54 19,831.50 13.82 3,831 14.57 54.46
2,122.75 96,839.34 37.44 20,141.50 19.94 1,936 73.53 42.49
1,157.85 67,248.12 18.88 29,559.20 17.55 3,169 8.66 33.24
5,179.30 61,926.30 28.99 12,978.40 9.84 1,812 14.16 36.01

Corporate Action

Technical Indicators

RSI(14)
Neutral
46.70
ATR(14)
Less Volatile
12.90
STOCH(9,6)
Neutral
41.36
STOCH RSI(14)
Neutral
30.85
MACD(12,26)
Bearish
-1.30
ADX(14)
Weak Trend
13.71
UO(9)
Bearish
47.64
ROC(12)
Downtrend And Accelerating
-7.92
WillR(14)
Neutral
-64.22